Correction to: Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation

On behalf of CSS-COVID 19 Group

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original version of the article, the group was mentioned incorrectly. The correct name is "CSS COVID-19 Group". Also, in the Table 4 the p for ICU access and CKD were 0.024 (instead of 0.24) and 0.006 (instead of 0.06). These have been corrected with this erratum.

Original languageEnglish (US)
Pages (from-to)980
Number of pages1
JournalJournal of Thrombosis and Thrombolysis
Volume52
Issue number3
DOIs
StatePublished - Oct 2021

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Correction to: Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation'. Together they form a unique fingerprint.

Cite this